Asthma

March 28, 2016March 28, 2016

FDA Approves Teva’s Asthma Drug Cinqair as Add-on Treatment

Asthma, News

Teva Pharmaceutical Industries recently announced the approval of Cinqair (reslizumab) injection by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for patients with severe asthma, age 18 and ... Read more

March 16, 2016March 16, 2016

People with Severe Asthma Are Focus of Study to Better Target Treatment of XolairR

Asthma, News

A new study developed by researchers at the National Institute for Health Research (NIHR) Southampton Respiratory Biomedical Research Unit in England and managed by the NIHR-funded Clinical Trials Unit at the University of ... Read more

March 15, 2016May 13, 2016

New Gene Study to Determine Why Some People Are More Prone to Developing Asthma

Asthma, News

New research from the University of Southampton in England is set to expand scientists’ knowledge about why some people are more prone to develop asthma by analyzing a gene called ADAM33 – typically ... Read more

March 11, 2016March 11, 2016

First 3D-Printed ‘Sneezeometer’ Has Potential to Quickly Help Patients of Asthma, Other Respiratory Diseases

Asthma, News

Scientists at the University of Surrey in Guildford, England, have created the world’s first Sneezeometer — an airflow sensor or spirometer device sufficiently sensitive to measure the speed of a sneeze ... Read more

March 8, 2016March 8, 2016

Allergic Asthma Patients Show Improvement by Adding Spiriva Respimat to Therapy, According to New Analyses of Data

Asthma, News

Boehringer Ingelheim Pharmaceuticals recently announced that adding its soft mist inhaler device Spiriva Respimat to deliver asthma maintenance drugs helps patients with allergic asthma better control their symptoms. The findings were presented at the ... Read more

March 7, 2016March 7, 2016

Two Phase 3 Trials for Asthma Drug Lebrikizumab Have Differing Results, Genentech Reports

Asthma, News

Genentech, a member of the Roche Group, recently reported top-line data from two Phase 3 clinical trials assessing the efficacy and safety of lebrikizumab in people with uncontrolled asthma despite ... Read more

March 4, 2016March 4, 2016

Genentech’s Application of Xolair for Allergic Asthma in Kids Is Under FDA Review

Asthma, News

Genentech recently announced that its supplemental Biologics License Application (sBLA) for extension of Xolair (omalizumab) in allergic asthma in pediatric patients has been accepted by the U.S. Food and Drug Administration (FDA). ... Read more

March 2, 2016March 2, 2016

Free Asthma Health App Expanded to UK and Ireland, According to Mount Sinai and LifeMap Solutions

Asthma, News

The Icahn School of Medicine at New York’s Mount Sinai Health System, one of the top medical school recipients of NIH funding, and innovative digital health development firm LifeMap Solutions have ... Read more

March 1, 2016March 1, 2016

Lung Disease Patients Need to Work Simple Exercises into Daily Routines, Study Advises

Asthma, Chronic Bronchitis, COPD, Emphysema, News

People with lung disease are advised to do short workouts throughout the day so as to maximize their capacity for physical activity, according to a recent review of studies on ... Read more

February 25, 2016February 25, 2016

Battle Against Respiratory Diseases Gets Boost from Propeller, Aptar Pharma Collaboration to Develop First Connected Drug Inhaler

Asthma, COPD, News

Propeller Health recently announced a partnership with Aptar Pharma to develop the first integrated connected metered dose inhaler (cMDI), containing an integrated sensor and an electronic dose counter which will ... Read more